MedPath

Increasing physical activity levels using e-bikes to enhance breast cancer survival

Not Applicable
Completed
Conditions
Breast cancer survival
Cancer
Registration Number
ISRCTN39112034
Lead Sponsor
niversity of Bristol
Brief Summary

2023 Protocol article in https://doi.org/10.1186/s40814-023-01293-3 (added 25/04/2023) 2024 Other publications in https://pubmed.ncbi.nlm.nih.gov/39151159/ The development of the CRANK intervention (added 19/08/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
40
Inclusion Criteria

1. Women with early breast cancer who have completed their primary breast cancer treatment (i.e., surgery, chemotherapy and/or radiation therapy)
2. Aged =18 years
3. Cleared for engaging in physical activity by the treating surgeon

For the instructor/coordinator interviews the inclusion criteria is that individuals have coordinated the CRANK project or delivered e-bike training to participants in the CRANK trial. For health care professionals the inclusion criteria for participating in the interviews is that they have been involved in identifying and/or recruiting individuals for the CRANK-B trial.

Exclusion Criteria

1. Engage in =150 minutes of moderate-to-vigorous physical activity per week
2. Individuals with metastatic disease
3. Uncontrolled hypertension (systolic blood pressure (BP) >160 mmHg and/or diastolic BP >90 mmHg), for which the individual is not taking medication
4. Comorbidities including myocardial infarction or stroke within the past six months or evidence of end-stage renal failure or liver disease, uncontrolled congestive heart failure or angina
5. Use of a mobility aid preventing cycling
6. No previous experience riding a bicycle
7. Any other contra-indications to exercise
8. Are unable to read and communicate in English

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Recruitment measured by the number of participants recruited by the end of the recruitment period <br>2. Retention rates measured by retention of sample by the end of the intervention<br>3. Adherence to the intervention and data collection methods, the fidelity of intervention delivery will be measured through observation checklists during the study intervention period<br>4. Perceptions of the intervention for the deliverers, recruiters, and participants through qualitative interviews after the study intervention <br>5. Safety or maintenance issues will be measured by record of incidents throughout the study intervention
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath